ACP6
Lysophosphatidic acid phosphatase type 6
Also known as: ACPL1, LPAP, PPA6_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NPH0
- Gene
- ACP6
- Ensembl
- ENSG00000162836
- Chromosome
- 1
- Canonical length
- 428 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This gene encodes a member of the histidine acid phosphatase protein family. The encoded protein hydrolyzes lysophosphatidic acid, which is involved in G protein-coupled receptor signaling, lipid raft modulation, and in balancing lipid composition within the cell. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2016]
Canonical amino-acid sequenceUniProt
428 residues, UniProt reviewed canonical sequence.
>Q9NPH0|ACP6
1 MITGVFSMRL WTPVGVLTSL AYCLHQRRVA LAELQEADGQ CPVDRSLLKL KMVQVVFRHG
61 ARSPLKPLPL EEQVEWNPQL LEVPPQTQFD YTVTNLAGGP KPYSPYDSQY HETTLKGGMF
121 AGQLTKVGMQ QMFALGERLR KNYVEDIPFL SPTFNPQEVF IRSTNIFRNL ESTRCLLAGL
181 FQCQKEGPII IHTDEADSEV LYPNYQSCWS LRQRTRGRRQ TASLQPGISE DLKKVKDRMG
241 IDSSDKVDFF ILLDNVAAEQ AHNLPSCPML KRFARMIEQR AVDTSLYILP KEDRESLQMA
301 VGPFLHILES NLLKAMDSAT APDKIRKLYL YAAHDVTFIP LLMTLGIFDH KWPPFAVDLT
361 MELYQHLESK EWFVQLYYHG KEQVPRGCPD GLCPLDMFLN AMSVYTLSPE KYHALCSQTQ
421 VMEVGNEELocalizationUniProt · AlphaFold · HPA
Whether an antibody against ACP6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 21 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 21 nTPM
- choroid plexus: 20 nTPM
- breast: 17 nTPM
- kidney: 16 nTPM
- epididymis: 15 nTPM
- thyroid gland: 15 nTPM
Single-cell type
- astrocytes: 91 nCPM
- distal convoluted tubule cells: 67 nCPM
- bergmann glia: 62 nCPM
- neutrophil progenitors: 59 nCPM
- loop of henle epithelial cells: 59 nCPM
- gonadotrophs: 56 nCPM
Immune cell
- T-reg: 15 nTPM
- eosinophil: 14 nTPM
- naive CD4 T-cell: 8.2 nTPM
- MAIT T-cell: 7.9 nTPM
- memory CD4 T-cell: 7.5 nTPM
- naive CD8 T-cell: 7.1 nTPM
Brain region
- choroid plexus: 17 nTPM
- midbrain: 16 nTPM
- cerebral cortex: 14 nTPM
- hypothalamus: 14 nTPM
- medulla oblongata: 14 nTPM
- thalamus: 14 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ACP6.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 90 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.39
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.68
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- hematopoietic progenitor cell differentiation
- lysobisphosphatidic acid metabolic process
- phosphatidic acid biosynthetic process
- phospholipid metabolic process
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ACP6 as an antibody target. Whether an autoantibody or antibody against ACP6 could matter depends on whether native ACP6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ACP6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ACP6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...